Compare RAYA & SRZN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RAYA | SRZN |
|---|---|---|
| Founded | 2019 | 2015 |
| Country | China | United States |
| Employees | N/A | 59 |
| Industry | Metal Fabrications | Medicinal Chemicals and Botanical Products |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.1M | 271.6M |
| IPO Year | 2021 | 2020 |
| Metric | RAYA | SRZN |
|---|---|---|
| Price | $1.95 | $30.07 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 6 |
| Target Price | N/A | ★ $48.40 |
| AVG Volume (30 Days) | 93.9K | ★ 796.2K |
| Earning Date | 04-17-2026 | 11-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $3,477,000.00 |
| Revenue This Year | N/A | $208.89 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.31 | $11.39 |
| 52 Week High | $7.18 | $37.83 |
| Indicator | RAYA | SRZN |
|---|---|---|
| Relative Strength Index (RSI) | 44.44 | 66.56 |
| Support Level | $1.65 | $23.55 |
| Resistance Level | $2.42 | $33.96 |
| Average True Range (ATR) | 0.27 | 2.29 |
| MACD | 0.00 | 1.63 |
| Stochastic Oscillator | 39.74 | 68.93 |
Erayak Power Solution Group Inc is engaged in the manufacturing, research and development (R&D), and wholesale and retail of power solution products. The group focuses on manufacturing new energy storage and inverter devices. Its product portfolio includes sine wave and off-grid inverters, inverters and gasoline generators, battery and smart chargers, and custom-designed products. The products are used principally in agricultural and industrial vehicles, recreational vehicles (RVs), electrical appliances, and outdoor living products. The company generates the majority of its revenue from Inverters. The company generates revenue from five main markets, which are China, Poland, Mexico, the U.K., and Portugal. It derives maximum revenue from China.
Surrozen Inc is a clinical-stage biotechnology company committed to discovering and developing drug candidates to selectively modulate the Wnt pathway, a critical mediator of tissue repair, in a broad range of organs and tissues. Its product candidate includes SZN-8141(for wet AMD, DME), SZN-413( For retinopathies) and SZN-8143 (for wet AMD, DME, UME).